Low socioeconomic status is a risk factor for CPAP acceptance among adult OSAS patients requiring treatment

Sleep

Volumn 32, Issue 4, 2009, Pages 545-552

  Simon Tuval, Tzahit ^a   Reuveni, Haim ^a   Greenberg Dotan, Sari ^a   Oksenberg, Arie ^b   Tal, Asher ^a   Tarasiuk, Ariel ^a,c  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b LOEWENSTEIN REHABILITATION HOSPITAL   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

CPAP; Greenberg Dotan S; Oksenberg A; OSAS; Patient support; Reuveni H; Simon Tuval T; Socioeconomic status; Tal A; Tarasiuk A. Low socioeconomic status is a risk factor for CPAP acceptance among adult OSAS patients requiring treatment. SLEEP; Treatment acceptance Citation

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATICS; PATIENT EDUCATION; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RISK FACTOR; SLEEP APNEA SYNDROME; SOCIAL STATUS; TREATMENT REFUSAL;

EID: 65249166515     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.1093/sleep/32.4.545     Document Type: Article

References (57)

1. Gay P, Weaver T, Loube D, Iber C, Positive Airway Pressure Task Force; Standards of Practice Committee; American Academy of Sleep Medicine. Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep 2006;29:381-401.
2. Weaver TE, Maislin G, Dinges DF, et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 2007;30:711-9.
3. McArdle N, Kingshott R, Engleman HM, Mackay TW, Douglas NJ. Partners of patients with sleep apnoea/hypopnoea syndrome: effect of CPAP treatment on sleep quality and quality of life. Thorax 2001;56:513-8.
4. Jenkinson C, Davies RJO, Mullins R, et al. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999;353:2100-5.
5. Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007;176:706-12.
6. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53.
7. Collard P, Pieters T, Aubert G, Delguste P, Rodenstein A. Compliance with nasal CPAP in obstructive sleep apnea patients. Sleep Med Rev 1997;1:33-44.
8. Weaver TE, Kribbs NB, Pack AI, et al. Night to night variability in CPAP use over the frst three months of treatment. Sleep 1997;20:278-83.
9. Krieger J, Kurtz D, Petiau C, Sforza E, Trautmann D. Long-term compliance with CPAP therapy in obstructive sleep apnea patients and in snorers. Sleep 1996;19:S136-43.
10. Budhiraja R, Parthasarathy S, Drake CL, et al. Early CPAP use identifes subsequent adherence to CPAP therapy. Sleep 2007;30:320-4.
11. Scharf SM, Seiden L, DeMore J, Carter-Pokras O. Racial differences in clinical presentation of patients with sleep-disordered breathing. Sleep Breath 2004;8:173-83.
12. Sin DD, Mayers I, Man GC, Pawluk L. Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study. Chest 2002;121:430-5.
13. Hui DS, Choy DKL, Li TST, et al. Determinants of continuous positive airway pressure compliance in a group of Chinese patients with obstructive sleep apnea. Chest 2001;120:170-6.
14. Whittle AT, Douglas NJ. Does the physiological success of CPAP titration predict clinical success? J Sleep Res 2000;9:201-6.
15. Brin, Y, Reuveni H, Greenberg-Dotan S, Tal, A, Tarasiuk, A CPAP purchasing is reduced due to combined effect of patient characteristics and health care policy. Isr Med Assoc J 2005;7:13-8.
16. Waldhorn RE, Herrick TW, Nguyen MC, O'Donnell AE, Sodero J, Potolicchio SJ. Long term compliance with nasal continuous positive airway pressure therapy of obstructive sleep apnea. Chest 1990;97:33-8.
17. Olsen S, Smith S, Oei T, Douglas J. Health belief model predicts adherence to CPAP before experience with CPAP. Eur Respir J 2008;32:710-7.
18. Hoy CJ, Vennelle M, Kingshott RN, Engleman HM, Douglas NJ. Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome? Am J Respir Crit Care Med 1999;159:1096-100.
19. Popescu G, Latham M, Allgar V, Elliott MW. Continuous positive airway pressure for sleep apnea/hypopnoea syndrome: usefulness of a 2-week trial to identify factors associated with long term use. Thorax 2001;56:727-33.
20. Hui DS, Chan JKW, Choy DKL, et al. Effects of augmented continuous positive airway pressure education and support on compliance and outcome in a Chinese population. Chest 2000;117:1410-6.
21. Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc 2008;5:173-8.
22. Fukuda Y, Nakamura K, Takano T. Accumulation of health risk behaviours is associated with lower socioeconomic status and women's urban residence: a multilevel analysis in Japan. BMC Public Health 2005;5:53.
23. Anand SS, Yusuf S, Jacobs R, et al. Risk factors, atherosclerosis, and cardiovascular disease among aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP). Lancet 2001;358,1147-53.
24. Mackenbach JP, Stirbu I, Roskam AJ, et al.; European Union Working Group on Socioeconomic Inequalities in Health. Socioeconomic inequalities in health in 22 European countries. N Engl J Med 2008;358:2468-81.
25. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002;165:1217-39.
26. Shah, BR, Hux, JE, Zinman, B Increasing rates of ischemic heart disease in the native population of Ontario, Canada. Arch Intern Med 2000;160:1862-6.
27. Tarasiuk A, Greenberg-Dotan S, Simon T, Tal A, Oksenberg A, Reuveni H. Low socioeconomic status is a risk factor for cardiovascular disease among adult OSAS patients requiring treatment. Chest 2006;130:766-73.
28. Greenberg H, Fleischman J, Gouda HE, et al. Disparities in obstructive sleep apnea and its management between a minority-serving institution and a voluntary hospital. Sleep Breath 2004;8:185-92.
29. Safeer RS, Cooke CE, Keenan J. The impact of health literacy on cardiovascular disease. Vasc Health Risk Manag 2006;2:457-64.
30. Mauro M, Taylor V, Wharton S, Sharma AM. Barriers to obesity treatment. Eur J Intern Med. 2008;19:173-80.
31. Kushida CA, Littner MR, Hirshkowitz M, et al.; American Academy of Sleep Medicine. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep 2006;29:375-80.
32. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-54.
33. Rotem AY, Sperber AD, Krugliak P, Freidman B, Tal A, Tarasiuk A. Polysomnography and actigraphy evidence of sleep fragmentation in irritable bowel syndrome. Sleep 2003;26:746-52.
34. Kump K, Whalen C, Tishler PV, et al. Assessment of the validity and utility of a sleep-symptom questionnaire. Am J Respir Crit Care Med 1994;150:735-41.
35. Reuveni H, Greenberg-Dotan S, Simon-Tuval T, Oksenberg A, Tarasiuk A. Young adult males with OSA consume high health care resources due to nonspecifc co-morbidity. Eur Respir J 2008;31:273-9.
36. Tarasiuk A, Greenberg-Dotan S, Simon T, Tal A, Oksenberg A, Reuveni H. Elderly with obstructive sleep apnea consume high health care resources due to elevated cardiovascular morbidity. J Am Geriatr Soc 2008;56:247-54.
37. Tarasiuk A, Greenberg-Dotan S, Brin YS, Simon T, Tal A, Reuveni H. Determinants affecting health care utilization in OSAS patients. Chest 2005;128:1310-4.
38. Olsen S, Smith S, Oei TP. Adherence to continuous positive airway pressure therapy in obstructive sleep apnoea sufferers: A theoretical approach to treatment adherence and intervention. Clin Psychol Rev 2008 Jul 18 [Epub ahead of print].
39. Rauscher H, Popp W, Wanke T, Zwick H. Acceptance of CPAP therapy for sleep apnea. Chest 1991;100:1019-23.
40. Engleman HM, Wild MR. Improving CPAP use by patients with the sleep apnea/hypopnea syndrome. Sleep Med Rev 2003;7:81-99.
41. Wolkove N, Baltzan M, Kamel H, Dabrusin R, Palayew M. Longterm compliance with continuous positive airway pressure in patients with obstructive sleep apnea Can Respir J 2008; 15:365-9.
42. Weaver TE, Maislin G, Dinges DF, et al. Self-effcacy in sleep apnea: instrument development and patient perceptions of obstructive sleep apnea risk, treatment beneft, and volition to use continuous positive airway pressure. Sleep 2003;26:727-32.
43. Becker MH, Maiman LA. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care 1975;13:10-24.
44. Williams LK, Joseph CL, Peterson EL, et al. Race-ethnicity, crime, and other factors associated with adherence to inhaled corticosteroids. J Allergy Clin Immunol 2007;119:168-75.
45. Kripke DF, Ancoli-Israel S, Klauber MR, Wingard DL, Mason WJ, Mullaney DJ. Prevalence of sleep-disordered breathing in ages 40- 64 years: a population-based survey. Sleep 1997;20:65-76.
46. Reuveni H, Sheizaf B, Elhayany A, et al. The effect of drug copayment policy on the purchase of prescription drugs for children with infections in the community. Health Policy 2002;62:1-13.
47. Kribbs NB, Pack AI, Kline LR, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993;147:4887-95.
48. Joo MJ, Herdegen JJ. Sleep apnea in an urban public hospital: assessment of severity and treatment adherence. J Clin Sleep Med 2007;3:285-8.
49. Lewis KE, Seale L, Bartle IE, Watkins AJ, Ebden P. Early predictors of CPAP use for the treatment of obstructive sleep apnea. Sleep 2004;27:134-8.
50. Kiely J, McNicholas W. Bed partners' assessment of nasal continuous positive airway pressure therapy in obstructive sleep apnea. Chest 1997;111:1261-5.
51. McFadyen TA, Espie CA, McArdle N, Douglas NJ, Engleman HM. Controlled, prospective trial of psychosocial function before and after continuous positive airway pressure therapy. Eur Respir J 2001;18:996-1002.
52. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-84.
53. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25.
54. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study .JAMA 2000;283:1829-36.
55. Reuveni H, Tarasiuk A, Wainstock T, Ziv A, Elchayani A, Tal A. Awareness level to obstructive sleep apnea syndrome during routine unstructured interviews of a standardized patient by primary care physicians. Sleep 2004;27:1518-25.
56. Lavie P. Sleep medicine - Time for a change. J Clin Sleep Med 2006;2:207-11.
57. Young T, Evans L, Finn L, Palta M. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep 1997;20:705-6.